The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations.Linvention concerne dune manière générale des composés antiviraux, et plus précisément des combinaisons de composés capables dinhiber le virus de lhépatite C (VHC), des compositions comprenant ces composés, ainsi que des procédés permettant de traiter lhépatite C au moyen de ces combinaisons.
